Related Experiment Video
Updated: Jun 3, 2026
05:34
Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Dyspnoea: underlying mechanisms and treatment
1Department of Anesthesiology, Graduate School of Medicine, Chiba University, 1-8-1 Inohanacho, Chiba 260-7860, Japan. nishinot@faculty.chiba-u.jp
British Journal of Anaesthesia
|March 8, 2011
Summary
Dyspnoea, or breathlessness, involves complex factors and is not a single sensation. Research suggests shared neural pathways with pain, offering new therapeutic approaches.
Area of Science:
- Respiratory Medicine
- Neuroscience
- Psychology
Background:
- Dyspnoea arises from intricate physiological, psychosocial, social, and environmental factors.
- Multiple sensory receptors contribute to dyspnoea, but no single receptor is solely responsible.
- Dyspnoea involves a complex interplay of afferent sensory information and respiratory motor commands.
Purpose of the Study:
- To explore the multifaceted nature of dyspnoea.
- To investigate the potential shared neurophysiological underpinnings between dyspnoea and pain.
- To identify novel therapeutic strategies for managing dyspnoea.
Main Methods:
- Review of current understanding of dyspnoea pathophysiology.
- Analysis of neuroimaging studies comparing dyspnoea and pain.
- Application of neurophysiological and psychophysical approaches.
Main Results:
- Dyspnoea is not a singular sensation, encompassing distinct experiences like air hunger, work/effort, and chest tightness.
- Dyspnoea possesses both sensory and affective dimensions, analogous to pain.
- Neuroimaging suggests shared neural substrates for pain and dyspnoea.
Conclusions:
- Understanding the shared neural pathways with pain can inform dyspnoea research.
- Effective dyspnoea treatment may benefit from therapeutic strategies similar to those used for pain management.
- Further research into the neurophysiology of dyspnoea is crucial for developing effective therapies.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:23Physiological Control of Respiration
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...